Catecholamine-Induced Muscle Weakness
- 1 May 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 34 (5) , 280-284
- https://doi.org/10.1001/archneur.1977.00500170034005
Abstract
• Infusions of epinephrine or levarterenol bitartrate into a rabbit nerve-muscle preparation decreased the force of the evoked twitch of anterior tibial and gastrocnemius-soleus muscles. The adverse effect of the catecholamines was not directly on skeletal muscle. The α receptor blocking drug phenoxybenzamine hydrochloride prevented the adverse effect of the catecholamines if it was given prior to catecholamine infusions and unmasked a weak augmentation of twitch tension. Taken with the finding of abnormal accumulation of catecholamine in human dystrophic muscle, the production of an experimental myopathy resembling human dystrophy by the monoamine oxidase inhibitor pargyline hydrochloride, and the finding of excessive levels of catecholamines in the tissues and urine of dystrophic animals, these experiments support the hypothesis that catecholamines could play a pathogenetic role in some dystrophic diseases of muscle.This publication has 6 references indexed in Scilit:
- Imipramine‐serotonin induced myopathyNeurology, 1976
- Abnormal Levels of Urinary Catecholamines in Dystrophic Mice and HamstersExperimental Biology and Medicine, 1976
- Serotonin-Induced Muscle WeaknessArchives of Neurology, 1974
- Serotonin and Platelet Function in Duchenne Muscular DystrophyArchives of Neurology, 1973
- Duchenne Muscular Dystrophy: Functional Ischemia Reproduces Its Characteristic LesionsScience, 1971
- Catecholamine distribution in mice afflicted with muscular dystrophyAmerican Journal of Physiology-Legacy Content, 1966